News & Perspective

Jun 02, 2003

Jun 02, 2003

SARS tests unreliable early in illness, WHO says

(CIDRAP News) – Available diagnostic tests for SARS (severe acute respiratory syndrome) are not sensitive enough to reliably detect the SARS virus in the first few days of illness, a limitation that makes the disease harder to control, the World Health Organization (WHO) said today.

Jun 16, 2003

Jun 16, 2003

WHO cancels some China travel warnings as SARS wanes

June 16, 2003 (CIDRAP News) – The World Health Organization (WHO) has canceled its travel warnings for several areas of China in response to the steady waning of SARS (severe acute respiratory syndrome) there.

Jun 20, 2003

Jun 20, 2003

ACIP: Don't broaden smallpox vaccination program now

(CIDRAP News) – Because of the risk of heart inflammation, the Advisory Committee on Immunization Practices (ACIP) recommended yesterday that the federal smallpox immunization program not expand now beyond smallpox response teams to the larger population of health workers and emergency responders.

Jun 25, 2003

Jun 25, 2003

WHO cancels SARS warning on travel to Beijing

(CIDRAP News) – The World Health Organization (WHO) yesterday canceled its warning against travel to Beijing, site of the world's largest SARS (severe acute respiratory syndrom) outbreak, signaling that the disease is finally under control in the Chinese capital.

Jun 27, 2003

Jun 27, 2003

Suspected SARS case in Japan ruled out

(CIDRAP News) – A Taiwanese man who was thought to have the first case of SARS (severe acute respiratory syndrome) in Japan does not have the disease after all, the World Health Organization (WHO) announced today.

Japanese health officials told the WHO that laboratory testing showed the man has influenza B, according to a WHO statement. The 33-year-old man arrived in Tokyo Jun 21 and experienced a high fever and other symptoms 2 days later.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»